Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. J. Lammerts van Bueren
Pre-Clinical Evaluation of CD38 Chimeric Antigen Receptor Engineered T Cells for the Treatment of Multiple Myeloma
Haematologica
Hematology
Related publications
Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
International Journal of Hematology
Hematology
Chimeric Antigen Receptor T Cells for the Treatment of Lymphoma
Annals of Lymphoma
768. Improved Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Refractory and Relapsed Leukemia
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Chimeric Antigen Receptor T-Cells
Cancer Journal
Cancer Research
Oncology
Chimeric Antigen Receptor T Cell Targeting B Cell Maturation Antigen Immunotherapy Is Promising for Multiple Myeloma
Annals of Hematology
Medicine
Hematology
Selinexor‐based Regimens for the Treatment of Myeloma Refractory to Chimeric Antigen Receptor T Cell Therapy
British Journal of Haematology
Hematology
247. Phase I Study of Second Generation Chimeric Antigen Receptor-Engineered T Cells Targeting IL13Rα2 for the Treatment of Glioblastoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins